Last updated on November 2017

"A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine"


Brief description of study

"A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine"

Detailed Study Description

A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous administration of TEV-48125 in adult patients with chronic migraine or episodic migraine

Clinical Study Identifier: TX82090

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Patient Recruitment

Cedar Crosse Research Center
Chicago, IL USA
  Connect »